Search Results 271-280 of 16966 for monoclonal antibody

1. A Study to Test the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer - Mayo Clinic

   Immunotherapy with monoclonal antibodies ... Patients who have a history of a severe hypersensitivity reaction to monoclonal antibody or pembrolizumab (MK-3475) ...

2. Pembrolizumab With or Without Anetumab Ravtansine in Treating Patients With Mesothelin-Positive Pleural Mesothelioma - Mayo Clinic

   Monoclonal antibodies, such as anetumab ... Patients who have received any monoclonal antibody therapy within 4 weeks prior to entering the study.

3. Margetuximab-cmkb (intravenous route) - Side effects & uses - Mayo Clinic

   Margetuximab-cmkb is a monoclonal antibody that changes the immune system to help control the growth of cancer cells. This medicine is to be given only by ...

4. A First-in-Human, Phase 1 Dose-Escalation and Cohort Expansion Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BJ-005 in Patients With Advanced Solid Tumor or Lymphoma - Mayo Clinic

   BJ-005 is a recombinant bifunctional molecule, composed of a humanized anti-PD-L1 IgG1 monoclonal antibody (mAb) fused with a portion of the extracellular ...

5. Tislelizumab-jsgr (intravenous route) - Side effects & uses - Mayo Clinic

   Tislelizumab-jsgr is a monoclonal antibody that changes the immune system to help control the growth of cancer cells. This medicine is to be given only by ...

6. Eosinophilic esophagitis - Diagnosis and treatment - Mayo Clinic

   Monoclonal antibodies. The Food and Drug Administration (FDA) recently ... Dupilumab is a type of medicine known as a monoclonal antibody. It works to ...

7. Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer Following Immunotherapy, Pragmatica-Lung Study - Mayo Clinic

   Ramucirumab is a monoclonal antibody that may prevent the growth of new blood vessels that tumors need to grow. I. Participation eligibility. Participant ...

8. Belantamab mafodotin-blmf (intravenous route) - Side effects & uses - Mayo Clinic

   ... monoclonal antibody, a proteasome inhibitor, and an immunomodulatory agent) that did not work well. This medicine is available only under a restricted ...

9. Clinical trials - Oncology (Medical)

   Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and lenalidomide may stop the ...

10. Trastuzumab-dkst (intravenous route) - Mayo Clinic

    Trastuzumab-dkst is a monoclonal antibody. It interferes with the growth of cancer cells, which are eventually destroyed by the body. Since the growth of ...